Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TumorGlow™: Indocyanine Green for Intraoperative Molecular Imaging of Solid Tumors
NCT04723810Phase 2Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Aug 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indocyanine green in solid tumor, sponsored by University of Pennsylvania. Started Aug 2024; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04723810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04723810.